Managers / Q4 2023 · view latest →
ADAR1 Capital Management, LLC
CIK 0001940272 · 3503 WILD CHERRY DRIVE, BUILDING 9, AUSTIN, TX, 78738 · 512-254-3790
Reported Value
$280M
Q4 2023
Positions
170
Filings on Record
11
2019–present window
Filed
Feb 14, 2024
original filing
Summary
Adar1 Capital Management, Llc reported $280M in U.S.-listed holdings across 170 positions for Q4 2023.
Its largest position, Royalty Pharma, represents 13.3% of the portfolio.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 66.4% · $186M
- Other · 25.0% · $70M
- ETP · 6.7% · $19M
- ADR · 1.9% · $5M
- Ltd Part · 0.0% · $13,640
- Other · 0.0% · $5,790
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.7B | 311 | May 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.4B | 270 | Feb 18, 2026 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2025 | $1.1B | 220 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $652M | 210 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $539M | 202 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $500M | 214 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $615M | 278 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $530M | 266 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $441M | 261 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $280M | 170 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.